The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

Washington State Office of the Attorney General, AbilTo, Kansas City Area Life Sciences Institute, Luxembourg National Research Fund, National Science Foundation, University of California Los ...

Attorneys representing detained Tufts University student Rumeysa Ozturk are arguing Monday for her immediate release.

People who have disrupted circadian rhythms suffer all kinds of negative effects, including higher rates of obesity, sleep ...

Currently, 13 states cover GLP-1 medications for obesity treatment ... law professor at Washington University. That's because the medications are also gaining approval to treat other conditions ...

"When something [like this award] drops in completely unexpected, that's nice, that's wonderful," Holst, a professor of ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...